Lexicon Pharmaceuticals, Inc. (LXRX) short interest & options flow
NASDAQLexicon Pharmaceuticals heads into its November 6 earnings report with short sellers backing away from one of the more heavily shorted small-cap biotech names, even as an activist investor holds nearly two-fifths of the company. The short-side retreat is the week's clearest signal. Short interest has dropped 6.7% over the past week to 6.6% of free float, and is down more than 20%…
- Market cap
- $792M
- Next earnings
- 5 Mar 2027
Key data as of 7 Nov 2026

LXRX news and analysis
RSSNo long-form analysis yet for LXRX. Pulse alerts and the live data picture are available on ORTEX.
Open LXRX on ORTEX →Want the live picture for LXRX?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for LXRX — free to start on ORTEX.
Sign up for free →Open LXRX on ORTEX